Patrick Trucchio analyst

Currently out of the existing stock ratings of Patrick Trucchio, 206 are a BUY (96.26%), 5 are a SELL (2.34%), 3 are a HOLD (1.4%).

Patrick Trucchio

Work Performance Price Targets & Ratings Chart

Analyst Patrick Trucchio, currently employed carries an average stock price target met ratio of 17.28% that have a potential upside of 29.6% achieved within 73 days. Previously, Patrick Trucchio worked at HCWAINWRIGHT.

Patrick Trucchio’s has documented 382 price targets and ratings displayed on 31 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on QURE, Uniqure NV at 09-Jul-2024.

Wall Street Analyst Patrick Trucchio

Analyst best performing recommendations are on MNMD (MIND MEDICINE ).
The best stock recommendation documented was for MNMD (MIND MEDICINE ) at 9/21/2022. The price target of $5 was fulfilled within 7 days with a profit of $1.39 (21.75%) receiving and performance score of 31.08.

Average potential price target upside

ALLK Allakos ALNY Alnylam Pharmaceuticals ATAI ATAI Life Sciences BV CMPS Compass Pathways Plc FLXN Flexion Therapeutics MNK Mallinckrodt plc CYBN Cybin  FSTX FStar Therapeutics FTRP Field Trip Health Ltd MNMD Mind Medicine  VIR Vir Biotechnology ALT Altimmune ARWR Arrowhead Pharmaceuticals ARNA Arena Pharmaceuticals BNTC Benitec Biopharma Ltd ADR DMTTF Small Pharma FIXX Homology Medicines FRLN Freeline Therapeutics Holdings Plc GHRS GH Research PLC IMCR Immunocore Holdings Ltd LBPH Longboard Pharmaceuticals MIST Milestone Pharmaceuticals MSSTF Mindset Pharma PRGO Perrigo Company PLC SLN Silence Therapeutics PLC DTIL Precision BioSciences GOSS Gossamer Bio IVVD Invivyd . ONCY Oncolytics Biotech QURE Uniqure NV SGMO Sangamo Therapeutics

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$2 (200.00%)


18 days ago

0/3 (0%)

$1.94 (183.02%)




5 months 27 days ago

6/6 (100%)

$-0.02 (-1.96%)



6 months 26 days ago

1/1 (100%)

$32.69 (83.16%)




$8 (800.00%)

1 years 2 months 3 days ago

2/4 (50%)

$4.84 (116.35%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Patrick Trucchio is most bullish on?

Potential upside of $139.49 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

Which stock is Patrick Trucchio is most reserved on?

Potential downside of $1.98 has been obtained for SGMO (SANGAMO THERAPEUTICS)

What Year was the first public recommendation made by Patrick Trucchio?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?